Analyst Price Target is $221.14
▲ +32.42% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Zoetis in the last 3 months. The average price target is $221.14, with a high forecast of $260.00 and a low forecast of $180.00. The average price target represents a 32.42% upside from the last price of $167.00.
Current Consensus is
The current consensus among 8 investment analysts is to buy stock in Zoetis. This Buy consensus rating has held steady for over two years.
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The United States segment is involved in U.S. market and regulatory activities. The International segment includes non-U.S. market and regulatory activities. The company was founded in 1952 and is headquartered in Parsippany, NJ.